Ultrashort Wave Electromagnetic Therapy Improves Glymphatic Drainage in Mice
Despite a number of approved devices and some widely used protocols (that are not very consistent from device to device and provider to provider), few electromagnetic therapies have demonstrated consistent benefits. Some research groups are focused on applying electromagnetic fields to the brain, specifically ultrashort wave fields that may act to reduce inflammation. Here, researchers note that short wave electromagnetic therapy improves the drainage of cerebrospinal fluid from the brain into the glymphatic system. This drainage declines with age for a range of different reasons, and this contributes to neurodegeneration by encouraging protein aggregates and other metabolic waste to accumulate in brain tissue. One of the reasons why drainage declines is that the water channel AQP-4 becomes mislocalized in astrocyte cells. AQP-4 needs to be in the extended endfeet structures of astrocytes, which wrap around the perivascular spaces used to transport fluid away from the brain, and in aged tissues AQP-4 is not correctly localized in large enough amounts for efficient passage of fluid. The electromagnetic therapy appears to function by improving AQP-4 localization.
The glymphatic system clears cerebral waste, yet strategies to enhance its function remain elusive. Here, we show that 40.68 MHz ultrashort wave (USW) rapidly enhances glymphatic bulk flow in healthy mice within 10 minutes. USW potentiates both glymphatic influx and efflux, concomitant with increased Delta wave neuronal synchronization, as confirmed by local field potentials and electroencephalograms. Chemogenetic silencing confirms that USW-driven glymphatic enhancement depends on neuronal activity, while pharmacological blockade of aquaporin-4 (AQP4) abolishes the effects, revealing dual reliance on neural dynamics and astrocytic water channels.
Mechanistically, USW-induced Delta oscillations promote AQP4 polarization, coupling synchronized firing to perivascular AQP4 redistribution. Moreover, USW ameliorates traumatic brain injury-induced cerebral edema and improves cognitive deficits in Alzheimer's model mice by restoring glymphatic function. Our findings establish USW as a non-invasive neuromodulatory strategy for enhancing glymphatic clearance, offering therapeutic potential for neurological disorders characterized by glymphatic dysfunction.